Neoadjuvant ADT + Darolutamide With Pembrolizumab, Followed by Adjuvant Pembrolizumab in Molecularly Stratified High-Risk Prostate Cancer

Abroad (travel likely)RecruitingPHASE2

Conditions

Prostate Cancer · High-risk Prostate Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Icahn School of Medicine at Mount Sinai, New York, New York, United States
Contact: Study coordinator (Darren Deoraj, MHA) · darren.deoraj@mountsinai.org
Contact: Principal Investigator (Ashutosh Tewari, MD)

Study leads

Ashutosh K Tewari, MD
Principal Investigator
Icahn School of Medicine at Mount Sinai
Dimple Chakravarty, PhD
Principal Investigator
Icahn School of Medicine at Mount Sinai

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Safety and Efficacy of AGN-INM176 in Prostate Patients With Rising PSA

Prostate Cancer

Abroad (travel likely)RecruitingPHASE1, PHASE2

Hershey, United States

Clinical Study on Neoadjuvant Therapy of Homoharringtonine Combined With Androgen Deprivation for Prostate Cancer

Prostate CA

Abroad (travel likely)RecruitingPHASE2

Nanjing, China · Nantong, China

Salvage Radiotherapy Combined With Androgen Deprivation Therapy (ADT) With or Without Rezvilutamide in the Treatment of Biochemical Recurrence After Radical Prostatectomy for Prostate Cancer

Prostate Cancer · Biochemical Recurrence

Abroad (travel likely)RecruitingPHASE2

Nanjing, China · Nanjing, China

A Study of Mental Health Care in People With Cancer

Breast Cancer · Colorectal Cancer · Lung Cancer

Abroad (travel likely)Recruiting

New York, United States